Aurora Cannabis shares are trading lower after-hours: here’s why
- Aurora Cannabis' revenue tanked 45% in Q4 on a year-over-year basis.
- Revenue from medical cannabis, however, jumped 9.0% in the recent quarter.
- Shares of the company are down about 2.0% in after-hours trading.
The U.S. listed shares of Aurora Cannabis Inc (NYSE: ACB) are down more than 2.0% in after-hours trading as the company said its revenue tanked 45% in the fiscal fourth quarter on a year-over-year basis.
Aurora remained in $106 million of net loss in its recent quarter versus the year-ago figure of $1.8 billion in net loss. The Canadian firm did not disclose its per-share loss for the quarter.
Are you looking for fast-news, hot-tips and market analysis? Sign-up for the Invezz newsletter, today.
The Edmonton-based firm generated $43 million in revenue – a decline from last year’s $54 million. According to FactSet, experts had forecast the company to post $44.67 million in revenue.
Other notable figures
The licensed producer of cannabis attributed the decline in Q4 revenue to weak consumer demand due to the Coronavirus restrictions. Revenue from medical cannabis, however, jumped 9% on an annualised basis in the fourth quarter.
Aurora valued its cash stature at $440.9 million at the end of its Q4. Cannabis flower prices were 42% in the recent quarter, as per the earnings press release.
CEO Martin’s comments
Commenting on the financial update on Monday, CEO Miguel Martin said:
With annual cost savings of approximately $60 to $80 million, we have a clear pathway to achieve Adjusted EBITDA profitability. Importantly, our considerable cash balance of $440.9 million, substantial improvement in working capital, and strong balance sheet support our organic growth and can be utilised for opportunistic M&A, particularly in the U.S.
The stock is still down more than 50% from its year-to-date high of $18.92 in February.